Clinical trials
Phase 2 Atherosclerosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 6 |
| 2010 | 3 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 49 |
| Recruiting | 5 |
| Not yet recruiting | 2 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 10 |
| University of Southern California | 4 |
| Eli Lilly and Company | 3 |
| NewAmsterdam Pharma | 3 |
| Novartis Pharmaceuticals | 3 |
| AstraZeneca | 2 |
| Emory University | 2 |
| Genentech, Inc. | 2 |
| GlaxoSmithKline | 2 |
| Indiana University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 62 |
| Cardiovascular Diseases | 17 |
| Coronary Artery Disease | 12 |
| Dyslipidemias | 11 |
| Inflammation | 9 |
| Hypercholesterolemia | 7 |
| Coronary Disease | 4 |
| Hyperlipidemias | 4 |
| Hypertension | 4 |
| Carotid Artery Diseases | 3 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.